Brooktree Capital Management Dexcom Inc Transaction History
Brooktree Capital Management
- $157 Million
- Q3 2025
A detailed history of Brooktree Capital Management transactions in Dexcom Inc stock. As of the latest transaction made, Brooktree Capital Management holds 41,880 shares of DXCM stock, worth $2.43 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
41,880
Previous 29,245
43.2%
Holding current value
$2.43 Million
Previous $2.55 Million
10.42%
% of portfolio
1.79%
Previous 1.69%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,090Shares Held
445MCall Options Held
6.78MPut Options Held
7.25M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct69.2MShares$4.01 Billion2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...